LOADING
Tag: III
Sanofi’s Anti-OX40 Blocker Falls ‘Well Below Expectations’ in Phase III Eczema Study – BioSpace
September 5, 2025
Sanofi’s Anti-OX40 Blocker Falls ‘Well Below Expectations’ in Phase III Eczema Study BioSpace Source link
chat_bubble0 Comment
visibility76 Views
Copy of – Reistone reports positive phase III results for ivarmacitinib in atopic dermatitis
November 22, 2022
Reistone Biopharma Co. Ltd. said both doses of the JAK1 inhibitor ivarmacitinib, tested against moderate to severe atopic dermatitis (AD) in a multinational phase III trial, met the study’s co-primary endpoints, delivering significant improvements on a common measure of disease severity vs. placebo. It’s the first National Class A new drug for AD that is […]
chat_bubble0 Comment
visibility398 Views